NCT07476378 2026-03-17Archonc-001Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase NA Not yet recruiting69 enrolled
NCT07299331 2025-12-23Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone LymphomaZhengzhou UniversityPhase NA Not yet recruiting50 enrolled